Macrophage Nuclear Receptor Corepressor 1 Deficiency Protects Against Ischemic Stroke in Mice

Shuai Shao,Yan-Lin Chen,Lin-Juan Du,Yuan Liu,Hong Zhu,Lu-Jun Zhou,Ting Liu,Wen-Zhen Lin,Fei Yu,Xiao-Xin Ma,Xue-Rui Shi,Xiao-Qian Meng,Yan Liu,Yong-Li Wang,Lan Bai,Xiao-Hua Zhang,Feng Jia,Sheng-Zhong Duan
DOI: https://doi.org/10.1007/s12265-021-10187-9
2022-01-01
Journal of Cardiovascular Translational Research
Abstract:Microglia/macrophage activation plays an essential role in Ischemic stroke (IS). Nuclear receptor corepressor 1 (NCoR1) has been identified as a vital regulator in macrophages. The present study aims to explore the functions of macrophage NCoR1 in IS. Macrophage NCoR1 knockout (MNKO) mice and littermate control mice were subjected to middle cerebral artery occlusion (MCAO). Our data showed that macrophage NCoR1 deficiency significantly reduced the infarct size and infarct volume as well as brain edema after MCAO. Additionally, MNKO induced less microglia/macrophage infiltration and activation, neuroinflammation, apoptosis of neuronal cells, and BBB disruption in brains after IS. Mechanistic studies revealed that NCoR1 interacted with LXRβ in microglia and MNKO impaired the activation of the Nuclear factor-κB signaling pathway in brains after IS. Our data demonstrated that macrophage NCoR1 deficiency inhibited microglia/macrophage activation and protected against IS. Targeting NCoR1 in microglia/macrophage may be a potential approach for IS treatment.
What problem does this paper attempt to address?